News: Novo Nordisk Q3 figures

Novo Nordisk a Danish pharmaceutical company specialized in diabetes care medications and devices just released their Q3 figures.

The highlights:

• Net Sales +2%
• Gross profit +1%
• Net profit +2%
• Earnings per share +5%
• Outlook FY 2017 between 3%-6% net profit increase